SERINC5: One antiviral factor to bind them all
PLOS Pathogens · 2023
DOI: 10.1371/journal.ppat.1011076 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Uddhav Timilsina und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, New York, United States of Ameri…. Hauptthemen laut MEDLINE: HIV-1, HIV Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, New York, United States of America.
ORCID-Profile: Spyridon Stavrou
Förderung
- NIAID NIH HHS
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Zitieren
APA
Timilsina, U., & Stavrou, S. (2023). SERINC5: One antiviral factor to bind them all. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011076
Vancouver
Timilsina U, Stavrou S. SERINC5: One antiviral factor to bind them all. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011076
BibTeX
@article{Timilsina2023,
author = {Timilsina, Uddhav and Stavrou, Spyridon},
title = {SERINC5: One antiviral factor to bind them all},
journal = {PLOS Pathogens},
year = {2023},
doi = {10.1371/journal.ppat.1011076}
}
EUVIMED